Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Biogen
Description:
An American biotechnology company that develops and commercializes medicines, particularly for neurological and neurodegenerative diseases.
Related topics:
Alzheimer's disease research and treatments (15%),
Pharmaceutical Economics and Policy (10%)
Wikidata ID:
wiki/Q864338
OpenAlex ID:
keywords/biogen
Effect of dietary probiotic Biogen � supplementation as a growth promoter on growth performance and feed utilization of Nile tilapia Oreochromis niloticus (L.)
2006
·
E R EL-Haroun
, A M A-S Goda
, et al.
·
Aquaculture Research
·
437
PDF
A resurrection of aducanumab for Alzheimer's disease
2019
·
Lon Schneider
·
The Lancet Neurology
·
313
PDF
The need for better measurement and employee engagement to advance a circular economy: Lessons from Biogen’s “zero waste” journey
2017
·
Vesela Veleva
, Gavin Bodkin
, et al.
·
Journal of Cleaner Production
·
283
Tofersen: First Approval
2023
·
Hannah A. Blair
·
Drugs
·
200
Landmark Alzheimer’s drug approval confounds research community
2021
·
Asher Mullard
·
Nature
·
162
PDF
Questions EMERGE as Biogen claims aducanumab turnaround
2019
·
Robert Howard
, Kathy Y. Liu
·
Nature Reviews Neurology
·
131
PDF
Can we learn lessons from the FDA’s approval of aducanumab?
2021
·
Kathy Y. Liu
, Robert Howard
·
Nature Reviews Neurology
·
114
PDF
Evaluation of Nigella sativa L (black seeds ; baraka), Allium sativum (garlic) and BIOGEN as feed additives on growth performance and immunostimulants of O. niloticus fingerlings
2002
·
As Diab
·
99
Effect of garlic, black seed and Biogen as immunostimulants on the growth and survival of Nile tilapia,Oreochromis niloticus(Teleostei: Cichlidae), and their response to artificial infection withPseudomonas fluorescens
2008
·
Ahmed S Diab
, Salah M Aly
, et al.
·
African Journal of Aquatic Science
·
81
Effect of Organic, Inorganic Fertilizers and Plant Spacing on the Growth and Yield of Cabbage
2017
·
Md Islam
, Golam Ferdous
, et al.
·
Agriculture
·
76
PDF
Effect of probiotics and some spices as feed additives on the performance and behaviour of the Nile tilapia, Oreochromis niloticus
2008
·
Magdy Soltan
, Said El-L
·
Egyptian Journal of Aquatic Biology and Fisheries
·
73
PDF
Three FDA advisory panel members resign over approval of Alzheimer’s drug
2021
·
Elisabeth Mahase
·
BMJ
·
56
Effects of dietary Biogen and sodium butyrate on hematological parameters, immune response, and histological characteristics of Nile tilapia (Oreochromis niloticus) fingerlings
2017
·
Tamer El-Sayed Ali
, Abdelfattah Mohamed El-Sayed
, et al.
·
Aquaculture International
·
52
The Problem of Aducanumab for the Treatment of Alzheimer Disease
2021
·
G. Caleb Alexander
, Jason Karlawish
·
Annals of Internal Medicine
·
51
Aducanumab as a Novel Treatment for Alzheimer’s Disease: A Decade of Hope, Controversies, and the Future
2021
·
Michael Esang
, Mayank Gupta
·
Cureus
·
47
PDF
Aduhelm: Biogen abandons Alzheimer’s drug after controversial approval left it unfunded by Medicare
2024
·
Owen Dyer
·
BMJ
·
45
Zuranolone: First Approval
2023
·
Young-A Heo
·
Drugs
·
43
End of the road for daclizumab in multiple sclerosis
2018
·
The Lancet
·
The Lancet
·
39
PDF
Growth Response of the Freshwater Prawn, Macrobrachium rosenbergii (De Man), to Diets Having Different Levels of Biogen®
2009
·
Amal Saad
, Madlen Habashy
, et al.
·
World Applied Sciences Journal
·
39
Effect of Biogen® and Myco-Ad® on the Growth Performance of Common Carp (Cyprinus carpio) Fed a Mycotoxin Contaminated Aquafeed
2011
·
H.M. Agouz
, W. Anwer
·
Journal of Fisheries and Aquatic Science
·
33
LRRK2-targeted Parkinson disease drug advances into phase III
2022
·
Katie Kingwell
·
Nature Reviews Drug Discovery
·
31
Aducanumab in Alzheimer’s Disease: A Critical Update
2023
·
Sumel Ashique
, Ekta Sirohi
, et al.
·
Current Medicinal Chemistry
·
28
Alzheimer's disease: expedition into the unknown
2016
·
The Lancet
·
The Lancet
·
27
Big win possible for Ionis/Biogen antisense drug in muscular atrophy
2016
·
Ken Garber
·
Nature Biotechnology
·
26
Accelerated Approval of Aducanumab: Where Do We Stand Now?
2021
·
Hedva Barenholtz Levy
·
Annals of Pharmacotherapy
·
23
PDF
Show more works
View as search
Works count:
418
Citation count:
3,052
Year
Topic
Type